eduKateSG · Why Science?
Treat cybersecurity as a continuing medical-device safety case
Use current FDA resources through the cyber-device definition, section 524B, lifecycle plans, software bills of materials, threat modelling, security architecture, testing, updates, vulnerability disclosure and postmarket monitoring.
Connected medical devices can move data, software commands and clinical decisions across networks. That makes cybersecurity part of safety: a loss of confidentiality matters, and so can a loss of integrity or availability.
FDA’s current premarket approach asks for a structured security case. The record joins device architecture, threat modelling, software components, testing, update processes and postmarket plans rather than treating security as one password setting.
Did you know? A software bill of materials, or SBOM, is an inventory of software components. It helps a manufacturer assess whether a newly disclosed component vulnerability is actually present in a particular device version.
This guide teaches cybersecurity and evidence literacy. It does not assess a specific product, network or vulnerability.
Chapter index
Chapters 1–9: statutory scope, threats, architecture and SBOMs
- 1. Cybersecurity is part of device safety
- 2. The cyber-device definition is specific
- 3. Premarket duties apply to cyber devices
- 4. A plan must monitor and address vulnerabilities
- 5. Updates and patches need a lifecycle process
- 6. The SBOM maps software components
- 7. Threat modelling connects hazards and controls
- 8. Security architecture shows defence in depth
- 9. Testing should challenge the security case
Chapters 10–17: verification, vulnerabilities, updates and postmarket monitoring
- 10. Coordinated vulnerability disclosure supports reporting
- 11. Known vulnerabilities need contextual assessment
- 12. Legacy and supported devices differ
- 13. Premarket and postmarket work are connected
- 14. Safety and security risk analyses interact
- 15. Software versions are evidence boundaries
- 16. Guidance dates matter
- 17. A strong cyber receipt is reproducible
Medical-device cybersecurity becomes a patient-safety question when software, connectivity, threats, controls and update plans remain connected. Unauthorized access, loss of availability, altered function or corrupted data can affect diagnosis, treatment and patient care. This turns a technical checklist into a traceable safety case.
Try this
Evidence question: Which official record or guidance supports the point about cybersecurity is part of device safety? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the identifier, date, source and one limit for cybersecurity is part of device safety. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Keep the identifier, retrieval date and source page in the note so the route can be repeated.
Evidence checkpoint
Record the evidence object for cybersecurity is part of device safety, its identifier or version context, and one limit that must remain visible.
FDA treats cybersecurity as part of device quality and total-product-lifecycle risk management. Section 524B defines a cyber device using software, internet connectivity and technological characteristics that could be vulnerable to cybersecurity threats. It also separates a known vulnerability from evidence of exploitation or patient harm.
Try this
Evidence question: Which official record or guidance supports the point about the cyber-device definition is specific? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the identifier, date, source and one limit for the cyber-device definition is specific. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. If a field is missing, write “not shown” and follow the official documentation rather than inventing a value.
Evidence checkpoint
Record the evidence object for the cyber-device definition is specific, its identifier or version context, and one limit that must remain visible.
A cyber device has a statutory definition, while many broader security recommendations can matter beyond that definition. Sponsors of premarket submissions for cyber devices must provide information demonstrating compliance with applicable section 524B cybersecurity requirements. Versions, threat models and update records make the route reproducible.
Try this
Evidence question: Which official record or guidance supports the point about premarket duties apply to cyber devices? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the identifier, date, source and one limit for premarket duties apply to cyber devices. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Before comparing two records, check that their object types, methods, versions and units really align.
Evidence checkpoint
Record the evidence object for premarket duties apply to cyber devices, its identifier or version context, and one limit that must remain visible.
CHAPTER 4 OF 17 · Define the cyber device
4. A plan must monitor and address vulnerabilities
Premarket documentation is a snapshot of a continuing security process, not a promise that vulnerabilities will never appear. Required information includes plans and procedures to monitor, identify and address postmarket cybersecurity vulnerabilities and exploits. Current FDA guidance and manufacturer notices must be checked again when software changes.
Try this
Evidence question: Which official record or guidance supports the point about a plan must monitor and address vulnerabilities? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the identifier, date, source and one limit for a plan must monitor and address vulnerabilities. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Finish by naming one supported statement and one stronger statement that still needs another evidence layer.
Evidence checkpoint
Record the evidence object for a plan must monitor and address vulnerabilities, its identifier or version context, and one limit that must remain visible.
CHAPTER 5 OF 17 · Build the security case
5. Updates and patches need a lifecycle process
Medical-device cybersecurity becomes a patient-safety question when software, connectivity, threats, controls and update plans remain connected. Cybersecurity planning includes designing, developing and maintaining processes and procedures for updates and patches across the product lifecycle. This turns a technical checklist into a traceable safety case.
Try this
Evidence question: Which official record or guidance supports the point about updates and patches need a lifecycle process? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the identifier, date, source and one limit for updates and patches need a lifecycle process. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Keep the identifier, retrieval date and source page in the note so the route can be repeated.
Evidence checkpoint
Record the evidence object for updates and patches need a lifecycle process, its identifier or version context, and one limit that must remain visible.
FDA treats cybersecurity as part of device quality and total-product-lifecycle risk management. A software bill of materials identifies commercial, open-source and off-the-shelf software components so vulnerabilities can be assessed against the device configuration. It also separates a known vulnerability from evidence of exploitation or patient harm.
Try this
Evidence question: Which official record or guidance supports the point about the sbom maps software components? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the identifier, date, source and one limit for the sbom maps software components. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. If a field is missing, write “not shown” and follow the official documentation rather than inventing a value.
Evidence checkpoint
Record the evidence object for the sbom maps software components, its identifier or version context, and one limit that must remain visible.
CHAPTER 7 OF 17 · Build the security case
7. Threat modelling connects hazards and controls
A cyber device has a statutory definition, while many broader security recommendations can matter beyond that definition. Threat models examine assets, interfaces, trust boundaries, attack paths and consequences, helping reviewers see why security controls were selected. Versions, threat models and update records make the route reproducible.
Try this
Evidence question: Which official record or guidance supports the point about threat modelling connects hazards and controls? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the identifier, date, source and one limit for threat modelling connects hazards and controls. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Before comparing two records, check that their object types, methods, versions and units really align.
Evidence checkpoint
Record the evidence object for threat modelling connects hazards and controls, its identifier or version context, and one limit that must remain visible.
CHAPTER 8 OF 17 · Build the security case
8. Security architecture shows defence in depth
Premarket documentation is a snapshot of a continuing security process, not a promise that vulnerabilities will never appear. Documentation can connect authentication, authorization, encryption, integrity, logging, segmentation, recovery and other controls with identified risks. Current FDA guidance and manufacturer notices must be checked again when software changes.
Try this
Evidence question: Which official record or guidance supports the point about security architecture shows defence in depth? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the identifier, date, source and one limit for security architecture shows defence in depth. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Finish by naming one supported statement and one stronger statement that still needs another evidence layer.
Evidence checkpoint
Record the evidence object for security architecture shows defence in depth, its identifier or version context, and one limit that must remain visible.
Medical-device cybersecurity becomes a patient-safety question when software, connectivity, threats, controls and update plans remain connected. Vulnerability testing, penetration testing, code analysis and other verification provide different evidence and should name versions, scope and unresolved findings. This turns a technical checklist into a traceable safety case.
Try this
Evidence question: Which official record or guidance supports the point about testing should challenge the security case? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the identifier, date, source and one limit for testing should challenge the security case. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Keep the identifier, retrieval date and source page in the note so the route can be repeated.
Evidence checkpoint
Record the evidence object for testing should challenge the security case, its identifier or version context, and one limit that must remain visible.
CHAPTER 10 OF 17 · Test the controls
10. Coordinated vulnerability disclosure supports reporting
FDA treats cybersecurity as part of device quality and total-product-lifecycle risk management. A clear disclosure process gives researchers and users a route to report potential vulnerabilities and allows manufacturers to triage and communicate. It also separates a known vulnerability from evidence of exploitation or patient harm.
Try this
Evidence question: Which official record or guidance supports the point about coordinated vulnerability disclosure supports reporting? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the identifier, date, source and one limit for coordinated vulnerability disclosure supports reporting. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. If a field is missing, write “not shown” and follow the official documentation rather than inventing a value.
Evidence checkpoint
Record the evidence object for coordinated vulnerability disclosure supports reporting, its identifier or version context, and one limit that must remain visible.
CHAPTER 11 OF 17 · Test the controls
11. Known vulnerabilities need contextual assessment
A cyber device has a statutory definition, while many broader security recommendations can matter beyond that definition. A published CVE or component issue does not by itself establish exploitability or clinical impact in a particular device configuration. Versions, threat models and update records make the route reproducible.
Try this
Evidence question: Which official record or guidance supports the point about known vulnerabilities need contextual assessment? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the identifier, date, source and one limit for known vulnerabilities need contextual assessment. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Before comparing two records, check that their object types, methods, versions and units really align.
Evidence checkpoint
Record the evidence object for known vulnerabilities need contextual assessment, its identifier or version context, and one limit that must remain visible.
Premarket documentation is a snapshot of a continuing security process, not a promise that vulnerabilities will never appear. Support periods, patch mechanisms, operating environments and compensating controls affect whether a vulnerability can be mitigated safely. Current FDA guidance and manufacturer notices must be checked again when software changes.
Try this
Evidence question: Which official record or guidance supports the point about legacy and supported devices differ? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the identifier, date, source and one limit for legacy and supported devices differ. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Finish by naming one supported statement and one stronger statement that still needs another evidence layer.
Evidence checkpoint
Record the evidence object for legacy and supported devices differ, its identifier or version context, and one limit that must remain visible.
CHAPTER 13 OF 17 · Maintain the lifecycle
13. Premarket and postmarket work are connected
Medical-device cybersecurity becomes a patient-safety question when software, connectivity, threats, controls and update plans remain connected. Secure design evidence at submission must flow into monitoring, incident response, updates, customer communication and later regulatory reporting. This turns a technical checklist into a traceable safety case.
Try this
Evidence question: Which official record or guidance supports the point about premarket and postmarket work are connected? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the identifier, date, source and one limit for premarket and postmarket work are connected. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Keep the identifier, retrieval date and source page in the note so the route can be repeated.
Evidence checkpoint
Record the evidence object for premarket and postmarket work are connected, its identifier or version context, and one limit that must remain visible.
CHAPTER 14 OF 17 · Maintain the lifecycle
14. Safety and security risk analyses interact
FDA treats cybersecurity as part of device quality and total-product-lifecycle risk management. Security controls can change usability, availability or clinical performance, so cybersecurity decisions should connect with broader risk management. It also separates a known vulnerability from evidence of exploitation or patient harm.
Try this
Evidence question: Which official record or guidance supports the point about safety and security risk analyses interact? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the identifier, date, source and one limit for safety and security risk analyses interact. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. If a field is missing, write “not shown” and follow the official documentation rather than inventing a value.
Evidence checkpoint
Record the evidence object for safety and security risk analyses interact, its identifier or version context, and one limit that must remain visible.
CHAPTER 15 OF 17 · Maintain the lifecycle
15. Software versions are evidence boundaries
A cyber device has a statutory definition, while many broader security recommendations can matter beyond that definition. A cybersecurity statement should name the device model, software or firmware version, deployment assumptions and date. Versions, threat models and update records make the route reproducible.
Try this
Evidence question: Which official record or guidance supports the point about software versions are evidence boundaries? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the identifier, date, source and one limit for software versions are evidence boundaries. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Before comparing two records, check that their object types, methods, versions and units really align.
Evidence checkpoint
Record the evidence object for software versions are evidence boundaries, its identifier or version context, and one limit that must remain visible.
Premarket documentation is a snapshot of a continuing security process, not a promise that vulnerabilities will never appear. FDA issued updated final premarket cybersecurity guidance in February 2026, so older checklists should be reconciled with the current document. Current FDA guidance and manufacturer notices must be checked again when software changes.
Try this
Evidence question: Which official record or guidance supports the point about guidance dates matter? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the identifier, date, source and one limit for guidance dates matter. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Finish by naming one supported statement and one stronger statement that still needs another evidence layer.
Evidence checkpoint
Record the evidence object for guidance dates matter, its identifier or version context, and one limit that must remain visible.
Medical-device cybersecurity becomes a patient-safety question when software, connectivity, threats, controls and update plans remain connected. Record the device, connectivity, cyber-device status, software versions, SBOM date, threat model, tests, residual risks, update policy, disclosure route and access date. This turns a technical checklist into a traceable safety case.
Try this
Evidence question: Which official record or guidance supports the point about a strong cyber receipt is reproducible? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Save the identifier, date, source and one limit for a strong cyber receipt is reproducible. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Keep the identifier, retrieval date and source page in the note so the route can be repeated.
Evidence checkpoint
Record the evidence object for a strong cyber receipt is reproducible, its identifier or version context, and one limit that must remain visible.
Contents · Previous chapter · Continue at the Science Learning Hub
A device-security claim is strongest when versions, threats, controls and maintenance stay connected
Premarket evidence shows how a manufacturer designed and tested a security approach at a defined point. Total-product-lifecycle evidence shows how the approach continues as threats and software change.
Save the device and software version, connectivity, cyber-device assessment, assets, threat model, architecture, SBOM version, tests, unresolved findings, update and patch process, disclosure route, postmarket monitoring, guidance version and access date.
| Reading object | What it can support | Question to keep visible |
|---|---|---|
| Cyber-device scope | Determines statutory premarket requirements | Which definition element applies? |
| Threat model | Maps assets, attack paths and consequences | Which assumptions bound it? |
| SBOM | Lists software components in a version | When was it generated? |
| Lifecycle plan | Monitors and addresses later vulnerabilities | How are users updated? |
Sources and next reading
Substantive resource claims in this article were checked against the primary pages below. A structured record is a route into evidence; it does not by itself prove a scientific conclusion. Recheck the live record, evidence labels and release context before using it in assessed work or research.
For a classroom enquiry, save a short research receipt containing the question, search terms, selected object, exact identifier, version, access date and the evidence boundary you observed. Add the file or page that supports each statement. This small routine turns browsing into accountable science learning and gives a teacher, classmate or future analyst a route they can independently follow.
Before sharing the conclusion, ask another reader to retrace the route without verbal hints. If they reach a different version, file or interpretation, improve the receipt and narrow the claim. Reproducibility begins with this practical check. It teaches careful reading, supports fair collaboration and keeps uncertainty visible while evidence moves from an online service into notes, analysis and a final explanation.
A useful final review separates five questions. What object was found? Which organisation or repository maintains it? What exact evidence was inspected? Which statement does that evidence support? What remains uncertain? Answer each question in one sentence, then connect every answer to a visible field, file or source page. This review catches common mistakes: citing a collection when a file supplied the value, treating the newest release as the analysed release, confusing permission with scientific suitability, or turning a discovery count into a conclusion. It also gives students a calm way to improve work. A missing detail becomes a next research step instead of an invitation to guess. When the route is complete, the final explanation can stay simple because the identifiers, dates, versions, limitations and supporting evidence are already organised underneath it.
Primary sources
- FDA Cybersecurity in Medical Devices — accessed 25 October 2026.
- FDA 2026 Premarket Cybersecurity Guidance — accessed 25 October 2026.
- FDA Medical Device Cybersecurity FAQs — accessed 25 October 2026.
- FDA Postmarket Cybersecurity Guidance — accessed 25 October 2026.
- FDA Digital Health Center of Excellence — accessed 25 October 2026.